{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1597853", "DateCompleted": {"Year": "1992", "Month": "07", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "35", "Issue": "11", "PubDate": {"Year": "1992", "Month": "May", "Day": "29"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.", "Pagination": {"StartPage": "1978", "EndPage": "1986", "MedlinePgn": "1978-86"}, "Abstract": {"AbstractText": ["Extracts of Homalanthus nutans, a plant used in Samoan herbal medicine, exhibited potent activity in an in vitro, tetrazolium-based assay which detects the inhibition of the cytopathic effects of human immunodeficiency virus (HIV-1). The active constituent was identified as prostratin, a relatively polar 12-deoxyphorbol ester. Noncytotoxic concentrations of prostratin from greater than or equal to 0.1 to greater than 25 microM protected T-lymphoblastoid CEM-SS and C-8166 cells from the killing effects of HIV-1. Cytoprotective concentrations of prostratin greater than or equal to 1 microM essentially stopped virus reproduction in these cell lines, as well as in the human monocytic cell line U937 and in freshly isolated human monocyte/macrophage cultures. Prostratin bound to and activated protein kinase C in vitro in CEM-SS cells and elicited other biochemical effects typical of phorbol esters in C3H10T1/2 cells; however, the compound does not appear to be a tumor promoter. In skin of CD-1 mice, high doses of prostratin induced ornithine decarboxylase only to 25-30% of the levels induced by typical phorbol esters at doses 1/30 or less than that used for prostratin, produced kinetics of edema formation characteristic of the nonpromoting 12-deoxyphorbol 13-phenylacetate, and failed to induce the acute or chronic hyperplasias typically caused by tumor-promoting phorbols at doses of 1/100 or less than that used for prostratin."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Discovery Research and Development, National Cancer Institute (NCI), Frederick Cancer Research & Development Center (FCRDC), Maryland 21702-1201."}], "LastName": "Gustafson", "ForeName": "K R", "Initials": "KR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cardellina", "ForeName": "J H", "Initials": "JH", "Suffix": "2nd"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "McMahon", "ForeName": "J B", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gulakowski", "ForeName": "R J", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ishitoya", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Szallasi", "ForeName": "Z", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lewin", "ForeName": "N E", "Initials": "NE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Blumberg", "ForeName": "P M", "Initials": "PM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Weislow", "ForeName": "O S", "Initials": "OS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Beutler", "ForeName": "J A", "Initials": "JA"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phorbol Esters"}, {"RegistryNumber": "60857-08-1", "NameOfSubstance": "prostratin"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C"}, {"RegistryNumber": "EC 4.1.1.17", "NameOfSubstance": "Ornithine Decarboxylase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cytopathogenic Effect, Viral"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Edema"}, {"QualifierName": ["drug effects"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hyperplasia"}, {"QualifierName": [], "DescriptorName": "Independent State of Samoa"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects", "microbiology"], "DescriptorName": "Monocytes"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Ornithine Decarboxylase"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Phorbol Esters"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Kinase C"}, {"QualifierName": ["drug effects", "enzymology", "pathology"], "DescriptorName": "Skin"}, {"QualifierName": ["drug effects", "microbiology"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "5", "Day": "29"}, {"Year": "1992", "Month": "5", "Day": "29", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "5", "Day": "29", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1597853", "10.1021/jm00089a006"]}}]}